TMO - Thermo Fisher Scientific, Inc. -  [ ]

Ticker Details
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $166.59B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.70 | 1.00%
Avg Daily Range (30 D): $5.77 | 1.20%
Avg Daily Range (90 D): $6.54 | 1.27%
Institutional Daily Volume
Avg Daily Volume: 1.83M
Avg Daily Volume (30 D): 1.91M
Avg Daily Volume (90 D): 1.9M
Trade Size
Avg Trade Size (Sh.): 90
Avg Trade Size (Sh.) (30 D): 29
Avg Trade Size (Sh.) (90 D): 29
Institutional Trades
Total Institutional Trades: 38,594
Avg Institutional Trade: $11.79M
Avg Institutional Trade (30 D): $38.06M
Avg Institutional Trade (90 D): $39.13M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 6
Market Closing Trades
Avg Closing Trade: $55.26M
Avg Closing Trade (30 D): $155.44M
Avg Closing Trade (90 D): $155.31M
Avg Closing Volume: 169.9K
 
News
May 26, 2026 @ 4:30 AM
[Latest] Global Bioprocess Automation Software Mar...
Source: Healthcare Foresights
May 21, 2026 @ 7:37 AM
Tissue Diagnostics Market to Reach USD 9.33 Bn by ...
Source: Mordor Intelligence
May 18, 2026 @ 7:07 PM
Dan Loeb Dumps Microsoft, Slashes Nvidia And Rail ...
Source: Lekha Gupta
May 18, 2026 @ 6:33 PM
Protein Synthesis Research Market to Reach $42.8 B...
Source: Bcc Research
May 14, 2026 @ 5:00 PM
Global Cervical Cancer Diagnostics Market to Exhib...
Source: Delveinsight
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $18.22 $4.44 $5.22
Diluted EPS $18.19 $4.43 $5.21
Revenue $45.2B $11.01B $12.22B
Gross Profit
Net Income / Loss $6.87B $1.66B $1.97B
Operating Income / Loss $7.89B $1.86B $2.26B
Cost of Revenue
Net Cash Flow $-1198M $-6676M $7.87B
PE Ratio